HORIZON 2020 Health, demographic change and wellbeing

Préparation aux 1ers appels d’Horizon 2020

1 NCP-Wallonie – 12 novembre 2013

Objectifs de la session

Ne pas rater d’opportunités

Thèmes et appels

Recherche d’un topic

Premières actions à mener

Trouver les meilleurs partenaires possibles

Services du NCP-Wallonie

2

The time is NOW

Drafts fiables

1ères recherches de partenaires circulent

Places limitées

Ne pas attendre le rush

3

Calendrier probable 2014

4

11/12/2013

Printemps

11/03 (+19/08)

15/04

fin 2014 /

début 2015

Publication

officielle

Dépôt des

projets

Résultat de

l’évaluation

Signature

contrat

Structuration

idée et

budget

Identification

partenaires

Rédaction Évaluation Finalisation

du contrat

Exécution

du projet

Maintenant

Draft appels

à projets

1 ou 2 étapes

(8 mois)

Ne pas rater d’opportunités

Horizon 2020 / 3 piliers : 79 milliards en 7 ans

NCP-Wallonie : 600 topics (2014/15)

Cette session : 45 topics

VOUS ?

5

Cf. liste

NCP

Se situer dans Horizon 2020

6

SOCIETAL CHALLENGES

1. Health, demographic change

and wellbeing (e-health)

2. Food Agriculture bioeconomy

3. Energy

4. Transport

5. Environment

6. Inclusive societies

7. Secure societies

INDUSTRIAL LEADERSHIP

(LEIT)

ICT

Nano, materials, biotech, and

processing

Space

Access to risk finance

Innovation in SMEs

EXCELLENT SCIENCE

ERC

FET

Marie Curie

Infrastructure

Session

05/11

Horizon 2020-SC1 “Health, demographic change and wellbeing”

Understanding health, ageing and disease (3)

Effective health promotion, disease prevention, preparedness and screening (6)

Improving diagnosis (3)

Innovative treatments and technologies (6)

Advancing active and healthy ageing (4)

Integrated, sustainable, citizen-centred care (7)

Improving health information, data exploitation and providing an evidence base for health policies and regulation (5)

co-ordination activities (15)

7

Understanding health, ageing and disease (3)

8

2014 ≈ 54M€ 2015 ≈ 66M€

Understanding health, ageing and disease: determinants, risk factors and pathways

Understanding diseases: systems medicine

Understanding common mechanisms of diseases and their relevance in co-morbidities

Effective health promotion, disease prevention, preparedness and screening (6)

9

2014 ≈ 84M€ 2015 ≈ 40M€

improved inter-sector co-operation for environment and health based interventions

translating ‘omics’ into stratified approaches

Evaluating existing screening and prevention programmes

infectious epidemics and foodborne outbreaks / rapid identification of pathogens

Vaccine development for Tuberculosis

Vaccine development for HIV/AIDS

Improving diagnosis (3)

10

2014 ≈ 114M€ 2015 ≈93M€

in vitro devices, assays and platforms

in vivo medical imaging technologies

Clinical validation of biomarkers and/or diagnostic medical SME instrument

2014 66M€

2015 45M€

Innovative treatments and technologies (6)

11

2014 ≈ 144M€ 2015 ≈158M€

New therapies for chronic non-communicable diseases

New therapies for rare diseases

Clinical research on regenerative medicine

Tools and technologies for advanced therapies

healthcare interventions in the elderly

healthcare interventions in the paediatric population

Advancing active and healthy ageing (4)

12

2014 ≈ xxM€ 2015 ≈xxM€

Topics influencés par la DG-CNECT = ICT

Principalement E-Santé

…

Promoting mental wellbeing in the ageing population

…

Integrated, sustainable, citizen-centred care (7)

13

2014 ≈ xxM€ 2015 ≈xxM€

Topics influencés par la DG-CNECT = ICT

new models for prevention oriented health and care systems

Piloting personalised medicine in health and care systems

Self-management of health and disease (citizen & mHealth)

Decision support systems based on predictive computer modelling used by the patient him or herself

…

Improving health information, data exploitation and providing an evidence base for health policies and regulation (5)

14

2014 ≈ xxM€ 2015 ≈xxM€

Topics influencés par la DG-CNECT = ICT

Digital representation of health data to improve disease diagnosis and treatment

Advancing bioinformatics to meet biomedical and clinical needs

New approaches to improve predictive human safety testing

co-ordination activities (15)

15

2014 ≈ xxM€ 2015 ≈xxM€

Topics Era-Net encore en discussion

Topics de coordination avec d’autres initiatives (EIP AHA, JPI MYBL,…)

Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes

CSA:

Support for international infectious disease preparedness research

New approaches to bridge the divide in European health research and innovation

Mobilisation and mutual learning action plan in the area of societal challenge 1

Autres parties de Horizon 2020

Sélection pour cette session: liste non exhaustive !

LEIT-NMP

nanomedicine, biomaterials for diabetes melitus / for Alzheimer…

SC2-Food, Agri & Bioeconomy

health risks of food-related toxic substances , malnutrition in the elderly

LEIT-Space

contamination and pollution of indoor environment, …

LEIT-ICT

technologies for better learning (neuroscience), …

SC7-Secure society

protection for large-scale pandemics, technologies to examine biological attack

16 05/11/2013

Autres parties de Horizon 2020

Sélection pour cette session: liste non exhaustive !

VOTRE sélection ?

NCP

Outil de la commission (après publication)

Votre réseau

Support interne

17 05/11/2013

Structure des topics

Specific Challenge

sets the context, the problem to be addressed, why intervention is necessary

Scope

delineates the problem, specifies the focus and the boundaries of the potential action BUT without overly describing specific approaches

Expected Impact

describe the key elements of what is expected to be achieved in relation to the specific challenge

Type of action

Research and innovation action (100%)

Innovation action (70%)

CSA

SME-Instrument

…

18

Le topic ne dit pas tout

19

The specific programme

tells us what to do, but

not how to do it

A strong challenge-based

approach, allowing applicants to

have considerable freedom to

come up with innovative solutions

Less prescription,

strong emphasis on

expected impact

Broader topics

Comprendre un topic

20

(2015): Personalised medicine in health …

Specific challenge: Personalised medicine has the potential to respond to…

Scope: Pilots of new models of care, based on the concept of personalised medicine will be conducted in existing health care environments and …

Expected impact: On the basis of quantitative and qualitative indicators, evidence for a validated model of organisation of care based on …

Type of action: Research and Innovation actions

Plateformes EU

Agendas stratégiques

Projets financés

3 conseils pour commencer

Oser initier les contacts

Viser l’excellence

Se faire aider

21

Nombreuses opportunités

Consortium composés de profils différents End-users

Sous-traitants

Experts mondiaux

Excellence du consortium par complémentarité

Niveaux d’implication variables

22

Plusieurs cas de figure au départ

23

J’ai une idée

et quelques

partenaires J’ai une

compétence à

mettre à

contribution

On cherche un bon

coordinateur

Démarche plus attentiste

Contacter le NCP

Se présenter

Attendre…

24

C’est bien si:

• Pas de projet prioritaire

• Trop de projets en cours

Mais le risque c’est de:

• Rater le coche

• Ne pas être prêt le moment venu

Démarche plus active

Initier les contacts

Trouver les meilleurs partenaires

Optimiser vos chances

25

• Activer le NCP & votre réseau

• Rechercher les meilleurs partenaires (NCP, Infodays, Brokerage, etc.)

• Viser l’excellence

Support du NCP

26

Informer Orienter Identifier et

sélectionner

Augmenter le

taux de succès

Déterminer le

programme

le plus pertinent

Recherche de

partenaires /

projets

internationaux

à fort potentiel

Eligibilité

Relecture

Conseils

Contacts directs

Web

Newsletters

Conférences

Save the date

Info Day on Societal Challenge 1

Brussels, 22 November 2013 (streaming only)

www.ncpwallonie.be

27

Merci de votre attention

28

François LOUESSE

European Project Developer

NCP Health

francois.louesse@ncpwallonie.be

010/48.50.33

29